Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shelley MD et al. – There are significant clinical benefits associated with the use of AHT for early prostate cancer. Patients should make an informed decision to accept AHT based on its effectiveness and side–effects.

Related Articles

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Cancer Immunology, Immunotherapy, 10/26/09    Relevance Score: 69%

Epac inhibits migration and proliferation of human prostate carcinoma cells
British Journal of Cancer, 11/20/09    Relevance Score: 68%

Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis
International Journal of Clinical Oncology, 10/30/09    Relevance Score: 67%

Widespread Metastases in Small Cell Carcinoma of the Prostate on FDG PET/CT
Clinical Nuclear Medicine, 10/06/09    Relevance Score: 67%

Testosterone therapy and prostate carcinoma
Current Urology Reports, 11/17/09    Relevance Score: 66%

Today in Clinical Pharmacology...keeping you current

Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non-Muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy
Urology, 12/02/09

High-grade prostate cancer and finasteride
BJU International, 12/02/09

Reboxetine in therapy-resistant enuresis: A retrospective evaluation
Scandinavian Journal of Urology and Nephrology, 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address